Sopharma AD (BUL:SFA)
Bulgaria · Delayed Price · Currency is EUR 3.130
-0.062 (-1.94%)
At close: Nov 12, 2026
Sopharma AD Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,685 | 740 | 490 | 465 | 277 | 284 | |
Market Cap Growth | 137.24% | 51.00% | 5.43% | 67.93% | -2.71% | 38.17% |
Enterprise Value | 1,964 | 1,061 | 693 | 672 | 430 | 454 |
Last Close Price | 3.13 | 1.36 | 0.90 | 0.86 | 0.53 | 0.53 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.75 | 10.83 | 12.52 | 9.47 | 7.61 | 6.21 |
Forward PE | - | 12.83 | 12.83 | 13.24 | 10.31 | 13.55 |
PS Ratio | 1.16 | 0.55 | 0.45 | 0.48 | 0.32 | 0.35 |
PB Ratio | 3.04 | 1.47 | 1.13 | 1.21 | 0.76 | 0.84 |
P/TBV Ratio | 4.13 | 2.08 | 1.72 | 1.34 | 0.83 | 0.96 |
P/FCF Ratio | 47.08 | - | 22.31 | 44.03 | 5.97 | - |
P/OCF Ratio | 27.68 | 77.96 | 12.46 | 20.18 | 4.92 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.35 | 0.79 | 0.63 | 0.70 | 0.50 | 0.55 |
EV/EBITDA Ratio | 13.77 | 10.09 | 10.35 | 10.28 | 7.07 | 9.47 |
EV/EBIT Ratio | 19.37 | 15.38 | 17.14 | 14.08 | 9.80 | 14.45 |
EV/FCF Ratio | 54.88 | - | 31.56 | 63.66 | 9.27 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.52 | 0.62 | 0.57 | 0.47 | 0.40 | 0.50 |
Debt / EBITDA Ratio | 2.30 | 2.93 | 3.59 | 2.41 | 2.10 | 2.95 |
Debt / FCF Ratio | 8.00 | - | 11.22 | 17.00 | 3.12 | - |
Net Debt / Equity Ratio | 0.47 | 0.55 | 0.53 | 0.30 | 0.37 | 0.45 |
Net Debt / EBITDA Ratio | 2.27 | 2.63 | 3.41 | 1.74 | 2.21 | 3.12 |
Net Debt / FCF Ratio | 7.32 | -20.47 | 10.39 | 10.75 | 2.90 | -3.04 |
Asset Turnover | 1.39 | 1.36 | 1.30 | 1.37 | 1.36 | 1.32 |
Inventory Turnover | 4.39 | 4.19 | 4.26 | 4.76 | 4.89 | 4.65 |
Quick Ratio | 0.74 | 0.67 | 0.49 | 0.70 | 0.66 | 0.70 |
Current Ratio | 1.43 | 1.30 | 1.10 | 1.29 | 1.41 | 1.35 |
Return on Equity (ROE) | 17.20% | 15.52% | 10.07% | 13.59% | 11.10% | 14.97% |
Return on Assets (ROA) | 4.98% | 4.35% | 2.98% | 4.21% | 4.37% | 3.14% |
Return on Invested Capital (ROIC) | 9.26% | 8.63% | 6.09% | 8.57% | 7.97% | 6.02% |
Return on Capital Employed (ROCE) | 12.20% | 10.90% | 7.70% | 10.30% | 10.10% | 7.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.27% | 9.23% | 7.99% | 10.56% | 13.14% | 16.09% |
FCF Yield | 2.12% | -1.83% | 4.48% | 2.27% | 16.76% | -17.32% |
Dividend Yield | 2.41% | 5.09% | 2.69% | 17.33% | 13.45% | - |
Payout Ratio | 35.71% | 10.19% | 220.73% | 74.90% | 0.01% | 0.07% |
Buyback Yield / Dilution | 25.97% | 30.63% | -19.21% | -10.64% | 0.36% | 0.31% |
Total Shareholder Return | 28.38% | 35.72% | -16.52% | 6.70% | 13.81% | 0.31% |